RxDoctor Payments Data

Mark Carroll, MD

Family Medicine · Colorado Springs, CONPI 1437121597

Payments from drug & device makers

$5,705in general payments, 2019–2025

Across 330 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$977
  • Boehringer Ingelheim$741
  • Novo Nordisk$507
  • Johnson & Johnson$492
  • Esperion Therapeutics, Inc.$368
  • Amgen$367
  • plus $2K from 41 others

What the payments were for

  • Food & beverage$5,705100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,705 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$1,125,049
Medicare patients
1,812
Services billed
15,167

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$62,351
XareltoRivaroxaban26$32,722
ShingrixVaricella-Zoster Ge/As01b/Pf131$29,142
TrulicityDulaglutide23$27,010
Stiolto RespimatTiotropium Br/Olodaterol Hcl18$22,902
Spiriva RespimatTiotropium Bromide19$22,852
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$22,350
JanuviaSitagliptin Phosphate15$22,168
MyrbetriqMirabegron29$21,474
RybelsusSemaglutide12$18,853
OzempicSemaglutide13$18,832
Tresiba Flextouch U-200Insulin Degludec13$17,026
MounjaroTirzepatide16$16,662
JardianceEmpagliflozin14$15,964
Boostrix TdapDiphth,pertuss(Acell),tet Vac196$13,738

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKShingrix, Trelegy Ellipta, Anoro Ellipta$130$63,458163 claims
PfizerEliquis$167$62,35140 claims
Boehringer IngelheimStiolto Respimat, Spiriva Respimat, Jardiance$741$61,71851 claims
Lilly USA, LLCTrulicity, Mounjaro$204$43,67339 claims
Novo NordiskRybelsus, Ozempic$507$37,68525 claims
Johnson & JohnsonXarelto$492$32,72226 claims
MerckJanuvia$108$22,16815 claims
Astellas Pharma US IncMyrbetriq$142$21,47429 claims
AbbVieSynthroid$977$3,20233 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →